Denali Therapeutics, Inc. (DNLI)
20.19
-0.05
(-0.25%)
USD |
NASDAQ |
Feb 20, 16:00
19.80
-0.39
(-1.93%)
After-Hours: 20:00
Denali Therapeutics SG&A Expense (Quarterly) : 35.48M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Protalix Biotherapeutics, Inc. | 2.929M |
| Enovis Corp. | 263.62M |
| Masimo Corp. | 116.40M |
| Twist Bioscience Corp. | 69.74M |
| Agenus, Inc. | 10.86M |